Your browser doesn't support javascript.
loading
Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia.
Huber, Henriette; Edenhofer, Simone; von Tresckow, Julia; Robrecht, Sandra; Zhang, Can; Tausch, Eugen; Schneider, Christof; Bloehdorn, Johannes; Fürstenau, Moritz; Dreger, Peter; Ritgen, Matthias; Illmer, Thomas; Illert, Anna L; Dürig, Jan; Böttcher, Sebastian; Niemann, Carsten U; Kneba, Michael; Fink, Anna-Maria; Fischer, Kirsten; Döhner, Hartmut; Hallek, Michael; Eichhorst, Barbara; Stilgenbauer, Stephan.
Afiliación
  • Huber H; Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
  • Edenhofer S; Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • von Tresckow J; Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
  • Robrecht S; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Zhang C; Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Tausch E; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Schneider C; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Bloehdorn J; Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
  • Fürstenau M; Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
  • Dreger P; Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
  • Ritgen M; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Illmer T; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Illert AL; Univerisitätsklinikum Schleswig-Holstein, Kiel, Germany.
  • Dürig J; Onkologie Dresden, Dresden, Germany.
  • Böttcher S; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Niemann CU; Universitätsklinikum Essen, Essen, Germany.
  • Kneba M; Universitätsklinikum Rostock, Rostock, Germany; and.
  • Fink AM; Rigshospitalet, Copenhagen, Denmark.
  • Fischer K; Univerisitätsklinikum Schleswig-Holstein, Kiel, Germany.
  • Döhner H; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Hallek M; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Eichhorst B; Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
  • Stilgenbauer S; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Blood ; 139(9): 1318-1329, 2022 03 03.
Article en En | MEDLINE | ID: mdl-35108374
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article